MBIO - ムスタング・バイオ （Mustang Bio Inc.）

Mustang Bio (MBIO) announced that it will effect a 15-for-1 reverse stock split of its issued and outstanding common stock.The stock is expected to commence trading on split-adjusted…

WORCESTER, Mass., April 03, 2023 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang” or the “Company”) (Nasdaq: MBIO), a clinical-stage biopharmaceutical company focused on translating today’s medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, solid tumors and rare genetic diseases, today announced that it will effect a 15-for-1 reverse stock split of its issued and outstanding common stock. Mustang expects its common stock to begin trading on a split-adjusted basis on the Nasdaq Capital Market as of the commencement of trading on April 4, 2023.

Mustang Bio press release (MBIO): FY GAAP EPS of -$0.75 beats by $0.01.As of December 31, 2022, Mustang’s cash and cash equivalents and restricted cash totaled $76.7 million, compared…

WORCESTER, Mass., March 29, 2023 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang”) (Nasdaq: MBIO), a clinical-stage biopharmaceutical company focused on translating today’s medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, solid tumors and rare genetic diseases, today announced financial results and recent corporate highlights for the full year ended December 31, 2022.

In last trading session, Mustang Bio Inc. (NASDAQ:MBIO) saw 0.55 million shares changing hands with its beta currently measuring 1.92. Company’s recent per share price level of $0.41 trading at -$0.05 or -8.84% at ring of the bell on the day assigns it a market valuation of $41.86M. That closing price of MBIO’s stock is … Mustang Bio Inc. (NASDAQ:MBIO) Stock Ripped 5.04% Year-To-Date, What Will Happen Next? Read More »

Mustang Bio Inc. (NASDAQ:MBIO) marked $0.41 per share on Tuesday, down from a previous closing price of $0.47. While Mustang Bio Inc. has underperformed by -13.06%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, MBIO fell by -78.87%, with highs and lows ranging from $2.18 to […]

Mustang Bio Inc. (NASDAQ:MBIO) closed Wednesday at $0.49 per share, down from $0.50 a day earlier. While Mustang Bio Inc. has underperformed by -1.01%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, MBIO fell by -77.21%, with highs and lows ranging from $2.20 to $0.40, whereas […]

A share of Mustang Bio Inc. (NASDAQ:MBIO) closed at $0.48 per share on Tuesday, down from $0.49 day before. While Mustang Bio Inc. has underperformed by -2.33%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, MBIO fell by -79.28%, with highs and lows ranging from $2.48 […]

Mustang Bio press release (MBIO): Q3 GAAP EPS of -$0.18 beats by $0.02.As of September 30, 2022, Mustang’s cash and cash equivalents and restricted cash totaled $92.4 million,…

WORCESTER, Mass., Nov. 14, 2022 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang”) (Nasdaq: MBIO), a clinical-stage biopharmaceutical company focused on translating today’s medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, solid tumors and rare genetic diseases, today announced financial results and recent corporate highlights for the third quarter ended September 30, 2022.

The following slide deck was published by Mustang Bio, Inc.

Mustang Bio (NASDAQ: MBIO ) reported its Q2 earnings results on Thursday, August 11, 2022 at 04:00 PM. Here''s what investors need to know about the announcement. Earnings Mustang Bio beat estimated earnings by 9.52%, reporting an EPS of … Full story available on Benzinga.com

Mustang Bio press release (MBIO): Q2 GAAP EPS of -$0.19 beats by $0.02.As of June 30, 2022, Mustang’s cash and cash equivalents and restricted cash totaled $108.4M.

WORCESTER, Mass., Aug. 11, 2022 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang”) (NASDAQ: MBIO), a clinical-stage biopharmaceutical company focused on translating today’s medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, solid tumors and rare genetic diseases, today announced financial results and recent corporate highlights for the second quarter ended June 30, 2022.

There are two main reasons why moving averages are useful in forex trading: moving averages help traders define trend recognize changes in trend. Now well have a look on, SMA50 … The post That Will Motivate You Today: Akerna Corp. (NASDAQ:KERN -3.76%), Mustang Bio, Inc. (NASDAQ:MBIO 1.60%) appeared first on Stocks Equity .